Mass screening of asymptomatic persons for severe acute respiratory syndrome coronavirus 2 using saliva I Yokota, PY Shane, K Okada, Y Unoki, Y Yang, T Inao, K Sakamaki, ... Clinical Infectious Diseases 73 (3), e559-e565, 2021 | 191 | 2021 |
Potential determinants of T helper 2 markers and their distribution in school-aged children H Goudarzi, A Ikeda-Araki, YA Bamai, S Ito, T Inao, I Yokota, C Miyashita, ... Allergology International 72 (1), 100-106, 2023 | 5 | 2023 |
Longitudinal mortality risks and kidney functional outcomes in Japanese living kidney donors T Hirose, K Hotta, T Osawa, I Yokota, T Inao, T Tanabe, N Iwahara, ... International Journal of Urology 31 (5), 519-524, 2024 | 1 | 2024 |
Evaluation of the Loopamp SARS-CoV-2 detection kit using saliva for the detection of SARS-CoV-2 Omicron S Oguri, S Iwasaki, T Inao, I Yokota, K Murakami, K Tanaka, K Hayasaka, ... Laboratory Medicine International 3 (3), 70-73, 2024 | | 2024 |
Exact sequential single-arm trial design with curtailment for binary endpoint T Inao, I Yokota arXiv preprint arXiv:2303.17091, 2023 | | 2023 |
Simulation studies on the estimation of sensitivity and specificity in the absence of a gold standard and with rare positive frequencies T Inao, K Okada, Y Yang, I Yokota Communications in Statistics-Simulation and Computation, 1-10, 2023 | | 2023 |
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan … K Izumiyama, T Inao, H Goto, S Harada, H Senjo, K Suto, J Hashiguchi, ... Haematologica, 2020 | | 2020 |